Webinar: Organizational Readiness for an FDA Audit of a 503B Compounding Pharmacy

Organizational Readiness for an FDA Audit of a 503B Compounding Pharmacy

Organizational Readiness for an FDA Audit of a 503B Compounding Pharmacy
May 4th, 2023 • 11 a.m. PT, 2 p.m. ET

Days
Hours
Minutes
Seconds
This event has expired.

Overview

In this webinar you’ll learn how to apply strategies for achieving an audit-ready organization, develop a better understanding of regulatory expectations and tune into the current regulatory environment. You will learn how to stay current on enforcement activity and how to effectively instill a regulatory mindset throughout the organization, so that your organization values both Internal and External audit programs. Finally, you will learn how to maintain vigilant management oversight.

Who should attend:

  • Lab Management – 503B Compounding Pharmacy
  • Quality Control/Assurance/Validation: Managers and Directors – 503B Compounding Pharmacy
  • Procurement – 503B Compounding Pharmacy
  • Management: C-Suite, Lab Owner – 503B Compounding Pharmacy
  • Regulatory Affairs professionals and Regulatory agencies – USP, FDA on 503B Compounding Pharmacy
 
 
Mike Auerbach

(Moderator)
Editor-in-Chief,
American Pharmaceutical Review

 

Share This!

Recently Added

The Importance of Regular Quality Control Product Testing: How Often is Ideal?

The Importance of Regular Quality Control Product Testing: How Often is Ideal?

Regular quality control product testing is a critical aspect of ensuring the overall quality and reliability of products. From electronics to pharmaceuticals, conducting frequent testing helps identify any potential issues or defects early on, preventing costly consequences down the line. But how often should companies perform these tests to strike the right balance between efficiency and effectiveness?

Read More »
Copy link